Schmidt-Erfurth U, Wetzel W, Dröge G, Häring G, Behrendt S, Birngruber R
Augenklinik der Medizinischen Universität, Lübeck.
Ophthalmologe. 1995 Aug;92(4):536-41.
In a previous study we presented our first results after sclerostomy using a pulsed erbium/holmium: YAG laser. At a fiber diameter of 300 microns a success rate of 20-30% was found after a 1-year follow-up. This study concentrates on the improvement of the parameters for filter survival. METHODS. The fiber diameter and thus the size of the fistula increased to 400 microns. Patients who had undergone fibrosis for a previous fistula were treated intraoperatively with topical mitomycin administration. RESULTS. After a follow-up of 6 months, filter function in the 300 microns group was maintained in 26% of the treated eyes (n = 23), while 400 microns fistulas were successful in 48% (n = 26). In the mitomycin-treated group (n = 6), sclerostomy achieved an IOP regulation in four patients. Postoperative hypotony was more frequent, but did not exceed 2 weeks. CONCLUSION. An increase in fistula diameter improves the long-term results of laser sclerostomy. Mitomycin is useful in maintaining filter function in patients with an unfavorable prognosis.
在之前的一项研究中,我们展示了使用脉冲铒/钬:YAG激光进行巩膜造口术后的首批结果。在光纤直径为300微米的情况下,1年随访后发现成功率为20%-30%。本研究着重于改善滤过泡存活的参数。方法:将光纤直径以及由此形成的瘘口大小增加到400微米。对于先前瘘口已发生纤维化的患者,术中给予局部丝裂霉素治疗。结果:随访6个月后,300微米组中26%(n = 23)的治疗眼维持了滤过功能,而400微米瘘口组的成功率为48%(n = 26)。在丝裂霉素治疗组(n = 6)中,巩膜造口术使4例患者眼压得到控制。术后低眼压更常见,但不超过2周。结论:瘘口直径增加可改善激光巩膜造口术的长期效果。丝裂霉素有助于维持预后不良患者的滤过功能。